2023 Speakers

Dr. Khalid Balaraj

Consultant Radiation Oncologist , Tawam Hospital | United Arab Emirates

Dr. Khalid Balaraj was initially trained in the United Kingdom. He has radiation oncology qualifications from - UK (FRCR (I), Ireland (FFR RCSI) and Canada (FRCPC). He has done 2 Clinical Fellowships from Canada, in Gynecology Brachytherapy and CNS Stereotactic Radiotherapy. Currently, Dr.Khalid Balaraj is a consultant radiation oncologist at Tawam Hospital, UAE.

Dr. AbdulRahman El Kinge

Medical Oncologist , Fakeeh University Hospital | United Arab Emirates

Dr. Abdul Rahman Agha El Kinge has an extensive experience in Medical Oncology. He has trained in Breast Cancer at the MD Anderson Cancer Center, USA, and he is also certified by the European Society of Medical Oncology. Dr. El Kinge is on the editorial board and a reviewer in multiple international medical journals. He is a Fellow of the American College of Physicians, and a member of local and international hematology and oncology societies. He has a keen interest in academics and as a result has multiple peer-reviewed publications. He has initiated and headed multiple oncology and hematology departments in KSA and UAE. He is the Chairperson of the yearly International Oncology and Supportive Care Congress. He has special interest and experience in Precision Medicine and Artificial intelligence in Cancer care.

Dr. Abdulwahhab Al Tourah

Consultant Medical Oncologist , Kuwait Cancer Centre | Saudi Arabia

Abdulwahab J. Al Tourah M.B., B.Ch., BAO, DABIM, FRCPC is a Consultant medical oncologist, Kuwait Cancer Centre, Ministry of Health. He is also Head of department of medical oncology, Kuwait Cancer Control Centre. He has long clinical experience in the treatment of breast cancer, lymphoma, and Myeloma. • Strong interest in cancer care delivery and integration with overall healthcare system • Interest in quality improvement in complex cancer care setting with focus on improving the patient’s experience and quality of cancer care delivery

Dr. Aly Abdel Razek

Chairman and Executive Director , Gulf International Cancer Center | United Arab Emirates

Dr. Abdel Razek graduated from Cairo University. He completed his residency in 1976 at Washington University in St. Louis, Mo., USA. He is board certified in both Radiation Oncology and Pediatrics. He co-authored four text books in radiation oncology and contributed to many publications in oncology journals. He served on the national committee of the Southwest Oncology Group, Intergroup Ewings Sarcoma and National Wilms Tumor Committee. Dr. Abdel Razek is a Fellow of the American College of Radiation Oncology. He is president of Medical Resources International and Chairman and Executive Director of the Gulf International Cancer Center.

Dr. Anwar Alnouri

Oncologist , Kuwait Cancer Control Centre | Kuwait

Consultant Medical Oncology at Kuwait Cancer Control Centre (KCCC). Clinical Research in Medical Oncology Fellowship (Breast)-McGill University. Associate Member of the American Society of Clinical Oncology. Fellow of the Royal College of Physicians & Surgeons of Canada. He has the Canadian Board Internal Medicine (FRCPC)

Dr. Aref Chehal

Adjunct Clinical Associate Professor of Medicine , Khalifa University | United Arab Emirates

Dr. Chehal is an Adjunct Clinical Associate Professor of Medicine, Gulf Medical University (GMU), Ajman, UAE Dr. Chehal is an Adjunct Clinical Associate Professor of Medicine, Khalifa University (KU), Abu Dhabi, UAE Dr. Chehal graduated from the college of Medicine at Baghdad University/Iraq (MBChB) in 1996. He did his Internal Medicine residency at Makassed General Hospital (Affiliated with American University of Beirut), Lebanon, between 1997 and 2000. He did his Hematology/Oncology fellowship at the American University of Beirut (AUBMC), Lebanon, between 2000 and 2003 (Lebanese Board). He obtained Fellowship of the American College of Physician (FACP) in 2013. He obtained the European Certification of Medical Oncology (ECMO) in 2009 and Re-certification in 2014 and 2021. Dr. Chehal is a member of many national and international societies including ASCO, ESMO, EHA,….. He had an important role in Tumor registry in Lebanon in 2002. Dr. Chehal acted as chairperson, moderator, advisor, and member of scientific committee in many local and international congresses. Dr. Chehal has 27 published articles in peer reviewed international journals; he is the first author on 9 of them, in addition to 31 abstracts. He joined Mafraq hospital From May 2006 until December 2019. He served as head of Hematology Oncology division at Mafraq Hospital from December 2018 till December 2019 His main interests are Lung cancer, Breast Cancer, GI malignancies and Lymphoma.

Dr. Ashish Chintakuntlawar

Consultant - Hematology & Oncology , Sheikh Shakhbout Medical City | United Arab Emirates

Dr. Chintakuntlawar is a certified Medical Oncologist by the American Board of Internal Medicine with expertise in treating head and neck cancers as well as endocrine cancers such as thyroid and adrenal carcinomas. His research interests include translational research and early phase clinical trials in head and neck and endocrine cancers. Dr. Chintakuntlawar is a member of the American Society of Clinical Oncology (ASCO), American Thyroid Association (ATA), International Thyroid Oncology Group (ITOG), and American-Australian-Asian Adrenal Alliance (A5), an international cooperative group dedicated to research related to adrenal diseases.

Dr. Aydah Awadhi

Consultant Physician , Tawam Hospital | United Arab Emirates

Medical Oncologist and quality officer in Oncology at Tawam hospital, graduated from the MD Anderson Hematology and Medical Oncology fellowship in 2019. Main interest in breast cancer. Published several peer review research articles and multiple book chapters in breast cancer.

Dr. Bassam Basulaiman

Consultant Medical Oncology , King Fahad Medical City | Saudi Arabia

Dr. Basulaiman is a Consultant in Medical Oncology – King Fahad Medical City and Chairman of the Scientific Committee at Saudi Arabia National Cancer Institute. He completed the Saudi Fellowship of Adult Medical Oncology in 2017, he had Clinical Fellowship of Genitourinary Oncology from Cancer Centre of Southeastern Ontario, Queen’s University, Kingston, Canada, in 2018 and he had Clinical Fellowship of Breast cancer from University of Ottawa, Canada, in 2019. His specialties are Clinical Oncology, Genitourinary Cancer, Breast Cancer, Gynecologic Oncology, Economic Evaluation of Health Technologies.

Dr. Bassim Bahrani

Consultant Medical Oncology , Royal Hospital Oman | Oman

Dr. Bassim AL Bahrani, is a renowned Medical oncology in the Sultanate of Oman who was the previous Director of National oncology center. He has a vast experience in the field for over 25 years. Part time Consultant Medical Oncologist and chief operating officer at the Gulf International Cancer Center. Working as Senior Consultant Medical Oncologist, Royal Hospital Muscat, Oman, and a visiting Professor at the Postgraduate Program on Health Economics, Management and Policy at the University of Peloponnese in Corinth, Greece. Worked as the Director of the National Oncology Center, Oman, Royal Hospital Oman for 9 years until December 2018. Done his advanced training in Medical Oncology in Australia and earned a fellowship from the Royal Australasian College of Physicians. He is an honorary Fellow of the Royal College of physicians and surgeons of Glasgow and Ph.D. from the University of Rome Tor Vergata. Chairman of the Ministry of Health Oman, and Royal Hospital Scientific and Research Committee, and deputy Chairman, Royal Hospital, Oman Scientific and Research Committee. Member of many Oncology associations, including the European Society of Medical Oncology, American Society of Clinical Oncology, Gulf Federation for Cancer Control, and Medical Oncology group of Australia.

Dr. Cherian Thampy

Consultant Medical Oncologist , NMC Hospital | United Arab Emirates

Dr. Cherian is a medical oncologist at NMC with 8 years’ experience in Oncology from the prestigious KIMS - Cancer Center in Trivandrum, India where he was working as Associate Consultant in Medical Oncology since 2015. Prior to KIMS, Dr. Cherian was working at the world renowned Cancer Institute, Chennai, India as an Assistant Professor of Medical Oncology. Dr. Cherian Thampy key areas of interest are: Gastrointestinal Oncology, Lymphomas, Breast Cancers and Immunotherapy He has also worked at SRMC, Chennai, India and Lakeshore Hospital, Kochi, India. Dr. Cherian Thampy completed MBBS from K.S. Hegde Medical Academy, Mangalore and thereafter obtained his MD in General Medicine from Sri Ramachandra Medical College, Chennai. He went on to complete his DM in Medical Oncology from The Cancer Institute, Chennai, India. Dr. Cherian Thampy successfully completed his MRCP Speciality certification in medical oncology. It is certified by the federation of royal college of physicians of United Kingdom and the association of cancer physicians.

Prof. Daniel Palmer

Professor and Honorary Consultant in Medical Oncology , Consultant Medical Oncologist | United Kingdom

Professor Palmer took his current position of North West Cancer Research Chair in Medical Oncology at the University of Liverpool in 2011. His research interests relate to HPB cancers (liver, pancreas and biliary tract) and incorporate basic laboratory science, translational research and clinical trials. His laboratory research is currently investigating novel therapeutic approaches to the treatment of HPB cancer through stimulation of anti-tumour immune responses and targeting tumour micro-environment including the tumour microbiome, and developing and validating biomarkers for a stratified approach to treatment. He is a member of the UK NCRN Upper GI cancers clinical studies group, and the hepatobiliary and pancreatic sub-groups. He is Director of the Cancer Research UK/NIHR Liverpool Experimental Cancer Medicine Centre and has established a portfolio of early phase clinical trials and translational studies and he is Chief Investigator for the TACE-3 and RaTIO trials investigating immunotherapy combinations for patients with intermediate and advanced HCC respectively.

Dr. Diaeddine Trad

Consultant Medical Oncologist , Tawam Hospital | United Arab Emirates

Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; non-small cell lung adenocarcinoma and locally advanced breast cancer. Dr. Trad was a speaker in many international conferences and forums.

Dr. Dina Hamza

Consultant Medical Oncologist , Dubai Health Authority | United Arab Emirates

Consultant medical oncology Completed training in Oncology 2001 National Cancer Institute - Masters degree in clinical Oncology Cairo University - Fellowship from ULM university Germany - European Board certified from European school of Oncology worked in different health care systems Working in Dubai since 2008 Had more than 20 publications in oncology the most citation was for the MENA Breast Guidelines; acknowledged by e-cancer search foundation Member of the most dynamic, scientific and leading organization; EOS

Dr. Dorai Ramanathan

Consultant Oncologist , Al Zahra Hospital | United Arab Emirates

Dr. Dorai Ramanathan is a highly qualified Oncologist from the United Kingdom with over 13 years’ experience in managing adult cancer patients alone. His expertise is both in Chemotherapy and Radiotherapy for all adult solid tumors. His sites of special interest are Breast, Lung, Gynaecological and Colon cancer.

Dr. Ehab Abdou

Clinical Oncologist , Kuwait Cancer Control Center | Saudi Arabia

Dr. Ehab ElSayed Mohamed Abdou is a clincial oncologist at Kuwait Cancer Control Center. Currently he is a consultant medical oncologist at Al-Hada Armed Forces Hospital. He is a Kuwait / Royal Marsden MDT members for head and neck cancer MDT. PSMA scan research scientific program member for RCC and brain glioma. Medical oncology Kuwaiti board program member, internal medicine, and gynecology Kuwaiti program member.

Dr. Emad Dawoud

Consultant Clinical Oncologist , Tawam Hospital | United Arab Emirates

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt . Dr. Dawoud completed his MD, PhD in clinical oncology since 2010, and Federation of Royal Colleague of physician of United Kingdom medical oncology speciality since 2012 and Master Degree in clinical Oncology since 2003. Dr Dawoud has been graduated from the Al Azhar University in Cairo Egypt since 1997 . Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Dr. Faisal Al Terkait

Medical Oncologist , Kuwait Cancer Control Center | Kuwait

Medical oncologist in Kuwait cancer control center from 2012, Head of breast unit from 2017 to 2021, inaugurated the first medical oncology departments outside kccc in Kuwait. Currently Head of Medical oncology department at Jaber al-Ahmad hospital in Kuwait. MRCP UK. MBBS UK. CCST ONCOLOGY UK

Dr. Faraz Khan

Head Of Hematology Program , American Hospital | United Arab Emirates

Asst Prof Dr. Faraz Khan is a Consultant Hematologist and Medical Oncologist with over 15 years experience in treating cancer and various blood diseases. He completed his Internal Medicine, Hematology and Medical oncology training from the University of Connecticut, CT, USA and is triple board certified in Internal medicine, Hematology and Medical Oncology. He worked as a consultant Hematologist/Medical Oncologist at PEI Cancer Treatment Center, PE, Canada and directed the provincial hemophilia and bleeding disorder clinic.

Dr. Farooq Latif

Consultant Medical Oncologist , Dubai Hospital | United Arab Emirates

Dr Farooq Latif is currently working as a consultant medical oncologist in Dubai Hospital. After graduation, Dr Farooq completed general internal medicine training in North Yorkshire, UK and attained MRCP in 2007. He then completed clinical oncology training in Liverpool, Merseyside leading to CCT. Dr Farooq became a fellow of Royal college of radiologist (FRCR), faculty of clinical oncology in 2013 and was subsequently awarded fellowship of Royal college of Physicians of Glasgow FRCP (Glasg) and fellowship of Royal college of physicians of Edinburgh FRCP(Edin). He worked as a consultant clinical oncologist in North Wales cancer centre and Royal stoke university hospital, Midlands, UK. He has keen interest in teaching and research and has published in peer-reviewed journals.

Dr. Fathi Azribi

Consultant Medical Oncologist , American Hospital Dubai | United Arab Emirates

Dr Fathi Azribi is a Consultant Medical Oncologist. He graduated from Tripoli University, Libya, then completed specialty training in Oncology in the UK and obtained a Certificate of Completion of Training in Medical Oncology. His main interest is in thoracic, breast, gynaecological and gastrointestinal malignancies, with expertise in treatment with chemotherapy, immunotherapy, hormonal, and targeted therapy. He published several papers and abstracts in peer reviewed journals. He also founded the first Medical Oncology Fellowship program in the UAE.

Dr. Hassan Ghazal

Consultant Medical Oncologist & Consultant Clinical Hematologist , Gulf International Cancer Center | United Arab Emirates

Dr Hassan Ghazal is an American board-certified Consultant Medical Oncologist and a Consultant Clinical hematologist offering more than 3 decades of clinical experience. Dr Hassan Ghazal, after doing his basic medical education in American University of Beirut, moved to US for his residency program in Internal Medicine at Sinai Hospital of Baltimore, MD. In 1992, completing the residency program, Dr Hassan Ghazal joined in George Washington university Medical Center for his fellowship in Medical Oncology and completed the same in 1995. He continued in George Washington University Medical Center for another 2 years and obtained his senior fellowship in bone marrow transplantation in the year 1997. He got his US board certification in Internal Medicine, Medical Oncology and in Hematology in the year 1992, 1995,1996 respectively. Except his association with CMC for the preceding 3 years, all his clinical practices were in US in various capacities including Director, Kentucky Cancer Clinic and Staff Oncologist/ Hematologist at Hazard Appalachian Regional Medical Center. Dr Hassan Ghazal is a member of various clinical societies such as American College of Physicians, American Society of Haematology, American Society of Clinical Oncology, European Society of Medical Oncology etc. Dr Hassan Ghazal has got many publications and abstracts in his credit, in peer reviewed journals, and there are many international recognitions and accolades in his name. He has been involved in numerous clinical trials, nearly 100, in the US, serving as Principal Investigator, for over 25 years, and enrolled hundreds of patients in these trials.

Dr. Hassan Shahryar

Consultant - Oncology , Sheikh Shakhbout Medical City | United Arab Emirates

Dr. Sheikh is certified by the American Boards of Internal Medicine, Geriatrics, Hematology, and Medical Oncology. He has expertise ranging from the diagnosis, and treatment of the benign and malignant disorders of the blood cells, lymph nodes, and bone marrow such as lymphoma, leukemia, and myeloma as well as tumors of the breast, lung, colon, rectum, prostate, kidneys, urinary bladder, esophagus, stomach, pancreas, ovaries among many others. In addition, Dr. Sheikh has a special focus on the management of older people with cancer requiring a comprehensive assessment. His research interests include clinical trials of novel agents, outcomes research, and geriatric oncology.

Dr. Hassan Jaafar

Consultant Medical Oncologist , Dubai Hospital | United Arab Emirates

Dr Farooq Latif is currently working as a consultant medical oncologist in Dubai Hospital. After graduation, Dr Farooq completed general internal medicine training in North Yorkshire, UK and attained MRCP in 2007. He then completed clinical oncology training in Liverpool, Merseyside leading to CCT. Dr Farooq became a fellow of Royal college of radiologist (FRCR), faculty of clinical oncology in 2013 and was subsequently awarded fellowship of Royal college of Physicians of Glasgow FRCP (Glasg) and fellowship of Royal college of physicians of Edinburgh FRCP(Edin). He worked as a consultant clinical oncologist in North Wales cancer centre and Royal stoke university hospital, Midlands, UK. He has keen interest in teaching and research and has published in peer-reviewed journals.

Dr. Husam Marashi

Consultant Clinical Oncologist , Tawam Hospital | United Arab Emirates

Dr Husam Marashi is a Consultant Clinical Oncologist based at the Beatson West of Scotland Cancer Centre and Rosshall Hospital. He underwent post graduate training at the West of Scotland hospitals and became a consultant in 2015. He developed a special interest in the non-surgical management of Upper gastro-intestinal and Breast malignancies including chemotherapy, radiotherapy, targeted therapy and immunotherapy. He is a principle investigator for many clinical trials and involved in many precision medicine programmes. He is also an active member of the oligometastasis SABR radiotherapy team. Dr Marashi has an active role in medical education/training for clinical oncology trainees in Scotland, and a member of RCR recruitment team. He is a member of the breast cancer MCN advisory board for the West of Scotland.

Dr. Jawaher Ansari

Chief of Medical Oncology , Tawam Hospital | United Arab Emirates

Dr Jawaher Ansari completed his Clinical Oncology specialist training in Birmingham, UK and worked as a Consultant at the Beatson Cancer Centre in Glasgow, the second largest cancer center in the UK, prior to moving to the Middle East. Dr Ansari has been a principal investigator for several international clinical trials and has authored several peer-reviewed publications and textbook chapters. He has a specialist interest in Urology, Breast and Lung cancers.

Dr. Maroun Maroun Khoury

Consultant Oncologist/ Hematologist , American Hospital | United Arab Emirates

Assistant Professor Doctor Maroun El Khoury Consultant Oncologist/ Hematologist at American Hospital in Dubai 9/2010-Present. Mayo Clinic Network (Jci Accredited), Director Of Cancer Care Center, President of Medical Staff: 2018-2020. Chairperson Scientific Committee, Emirates Oncology Society: 2018-2020 .7/2006-8/2010: Private Practice In The Us/Iowa: Medical Director Of Oncology And Hematology Services And Chief Of Medicine At Great River Health System .7/2006-2010: Hospice Medical Co-Director .Epec (Education In Palliative And End-Of-Life Care) Trainer.

Prof. Michael Gnant

Professor of Surgery , Medical University of Vienna | Austria

Dr. Michael Gnant is Professor of Surgery at the Medical University of Vienna, Austria, where he also serves as President of the Austrian Breast and Colorectal Cancer Study Group.Dr. Gnant’s research interests include several fields of surgical oncology, in particular breast, colorectal and pancreatic cancer, immunotherapy using antibodies, vaccination with dendritic cells, endocrine intervention, dormant tumor cells, the use of bone targeted treatments in order to silence tumor micrometastases, and pathway directed therapies such as mTOR and CDK 4/6 inhibition. He has been the Principal Investigator of more than 30 clinical trials.

Dr. Mohammed Asha

Consultant Neurosurgeon , Tawam Hospital | United Arab Emirates

Surgeons, FRCS (SN) and Certificate of Completion of Specialist Training in Neurosurgery (CCST) . Following his specialist training, He pursued sub-specialty fellowship in open and endoscopic skull base neurosurgery at Queen Elizabeth Hospitals, Birmingham, U.K and subsequently completed further endoscopic skull base fellowship and Diploma at the University of Paris, France. He also obtained another fellowship in Skull base and Neuroncology surgery at the University of Toronto, Canada working with professor Fred Gentili. Dr Asha is the author of a large number of peer reviewed journal articles and holds academic degrees in evidence-based medicine (MSc Cardiff University) and medical education (Diploma, University of Toronto). He has a dedicated skull base and neuroncology practice and has keen interest in complex open and endoscopic skull base tumors as well as advance neuroncology surgical techniques including awake craniotomy and intraoperative brain mapping.

Dr. Muhammad Nasim

Consultant Physician , Tawam Hospital | United Arab Emirates

Dr. Muhammad Nasim is a medical oncologist with a patient-centred approach. Throughout his oncology career, he has collaborated with multidisciplinary professionals and scientists to improve clinical outcomes for patients. His team based approach and interdisciplinary communication skills aids the smooth delivery of oncology service at this hospital. He has over 7 years’ experience as consultant Medical oncologist, having gained comprehensive site specific experience in colorectal, Gynae and Carcinoma of unknown primary (CUP), being lead for CUP, Acute Oncology and Chemotherapy subgroup, having set up CUP services at SaTH, and having managed wide variety of patients with malignancies of these tumor sites. He has represented oncology in peer review meetings for CUP and Acute oncology, and in Annual General meetings for colorectal and Gynae.

Dr. Nouri Bennini

Consultant Oncologist , Tawam Hospital | United Arab Emirates

Nouri Bennini has served as Consultant Oncologist at the Tawam Hospital in Al Ain, United Arab Emirates, since 1999. He received his general medicine diploma in 1988 from the University of Constantine in Algeria and undertook residency in medical oncology at the University of Bordeaux, France. At the University of Montpellier, France, Dr Bennini specialised in breast diseases. He has published several scientific papers and contributed to a number of oncology conferences.

Dr. Olga Oikonomidou

Consultant Medical Oncologist , University of Edinburgh | United Kingdom

Dr Olga Oikonomidou is an Academic Consultant Medical Oncologist with special interest in breast cancer at the Institute of Genetics and Cancer in Cancer Research UK Edinburgh Centre, University of Edinburgh. Other than a degree in Medicine, she holds a BSc in Human Genetics, MSc in Oncology, MRes in Immunology and a PhD in translational medicine. After completing her training in medical oncology at King’s College Hospital and Guy’s Hospital in London, she moved to Edinburgh where she worked as a Senior Clinical Research Fellow in Breast Cancer at the Cancer Research UK Edinburgh Centre and Edinburgh Cancer Centre at Western General Hospital for 2 years before getting a substantive post as an Academic Consultant Medical Oncologist with special interest in breast cancer. Soon after she set up her own research group in Breast Cancer Translational Research. Her responsibilities are split between running a busy breast oncology practice and a large portfolio of clinical trials and leading on breast cancer translational studies. Dr Oikonomidou is a clinical expert for NICE and SMC and has been involved in numerous technology appraisals since 2015. She is an active member of several professional societies including ACP, ESMO, ASCO and EORTC. She is the editor of the National Academy online Systemic Treatment Breast Cancer Session. She has received a number of prestigious grants for her clinical research projects. She is on the TMG of numerous national and international trials. She is currently the global Chief Investigator of 2 multinational multicentre trials, UK Chief Investigator on 4 clinical trials and the local PI for more than 20 trials. She is acting as a reviewer for MRC, NIHR and CRUK. Her academic research interest is focused on prediction of biomarkers of response to treatment and clinical trials in breast cancer in all phases.

Dr. Ramanujam Singarachari

Medical Oncologist , Sheikh Khalifa Medical City | United Arab Emirates

Dr. Ramanujam Singarachari came to SKMC in 2009 from Auckland City Hospital, New Zealand after 3 years of higher training in Medical Oncology. He has completed his Medical Oncology Super-Specialty Degree (DM) in 2001 from Cancer Institute, Chennai, India and subsequently worked as faculty at regional cancer centers in India, before joining as senior staff specialist at Dubai Hospital, UAE. He is certified and recertified (2019) from European Society of Medical Oncology. He is also certified in Medical Oncology by the Federation of Royal Colleges of Physicians of the United Kingdom and the Association of Cancer Physicians. His areas of interest are GI cancers, Breast cancers, CNS cancers and Palliative Care.

Dr. Rana Mahmood

Consultant Oncologist , Mediclinic City Hospital | United Arab Emirates

Dr Rana Mahmood trained in UK and has been a consultant in oncology for last 15 years. Dr Mahmood has special interest in advance image guided radiotherapy, SABR and image based High Dose rate Brachytherapy. He is the first to introduce and only practitioner to provide Gynaecological interstitial brachytherapy in UAE. He has setup the only service in UAE to provide prostate Brachytherapy and trans-perineal spacer device. He has been principal investigator for several landmark radiotherapy trials and extensively published his work.

Dr. Saeed Rafii

Medical Oncologist , Mediclinic Middle East | United Arab Emirates

Dr. Saeed Rafii is a UK trained and board certified consultant medical oncologist. After completion of his primary medical degree he was trained in internal medicine followed by subspeciality training in medical oncology in two of the most prestigious cancer hospitals in the UK, Queen Elizabeth Hospital Birmingham and the Royal Marsden Hospital, London. He then completed clinical fellowship in early phase clinical trials at the Royal Marsden Hospital, London and received his CCT (certificate of completion of training) from the UK General Medical Council. Dr Rafii was subsequently appointed as associate professor and consultant in medical oncology at the University of Manchester and the Christie hospital, one of the largest cancer hospitals in Europe, where he helped to establish and expand the Experimental Cancer Medicine Centre. He then moved to University College London Hospital and Oxford cancer network as a consultant medical oncologist. He has an extensive expertise in clinical trials and has been Chief, Principal or Co-investigator on over 100 early and late phase oncology clinical trials. Dr Rafii also holds a PhD and a postdoctoral fellowship in molecular cancer genetics. He is a member of the Royal College of Physicians of the UK, European Society of Medical Oncology (ESMO) and American Association for Clinical Oncology (ASCO). In 2018 he was elected as Fellow of the Royal College of Physicians of UK (FRCP) for his outstanding medical and research activities.

Dr. Selvaraj Giridharan

Consultant Clincial Oncologist , Tawam Hospital | United Arab Emirates

Dr Selvaraj Giridharan is a highly skilled and experienced oncologist with dual accreditation from the UK. He completed his Bachelor’s Medical degree from the University of Madras in 1993 and went on to continue his training in the UK, he became a member of Royal college of Physicians in 1998 and then achieved clinical oncology Fellowship in 2004. He worked as a consultant clinical oncologist in University Hospitals of North Midlands from 2004 to 2022 until his appointment to Tawam Hospitals in September this year. During his time in Stoke he held several additional roles including being services lead, audit lead, research lead, appraiser and clinical tutor. He has published extensively and has been a PI and SI for more than 30 clinical trials.

Dr. Sharif Kullab

Consultant Medical Oncology , King Saud University Medical City | Saudi Arabia

Dr. Sharif Kullab is Consultant Medical Oncologist, and Program Director for Adult Medical Oncology : King Saud University/ Riyadh. Working at Oncology Center / King Saud University Medical City (KSUMC) since June 2016. After his “MD Medical Thesis” in 2006, he did his medical training in the Field of Medical Oncology, and Fellowship at Jean Perrin Comprehensive Cancer Center (CJP) in Clermont Ferrand / France. • He has full registration at The French General Medical Council since 2015. • Worked as consultant medical oncology at CJP/ Clermont Ferrand • Then he was Head of Department of Oncology at Moulins Hospital in France. • During his working in France, he was actively participating in clinical researches and was investigator / coinvestigator in different national and international clinical trials

Prof. Syed Hussain

Professor and Consultant in Medical Oncology , Daniel Palmer | United Kingdom

Professor Hussain graduated from Dow Medical College Karachi in 1994. He completed his general medical professional training in UK. He did his Doctorate in Oncology from University of Birmingham. He then completed his Medical oncology training in Birmingham, United Kingdom and received his certification and specialist registration in Medical oncology. Professor Hussain is Professor and Consultant in Medical Oncology at the University of Sheffield and Sheffield Teaching Hospitals NHS Trust. His major areas of interest are management of urological cancers, clinical trials, early drug development and translational medicine. He has set up large number of clinical trials from early phase to late phase studies during his career. His work on organ preservation in bladder cancer moved all the way from an early phase I study (Hussain et al Annals of Oncology 2001) to phase II efficacy study (Hussain et al BJC 2004) that led to a Cancer Research UK funded study BC2001 trial that was reported in New England Journal of Medicine (James, Hussain, Hall et al April 2012). This study has now changed the standard of care for patients with muscle invasive bladder cancer opting for organ preservation treatment. Professor Hussain is principal investigator of number of studies in urological cancers. He is a chief investigator of a national randomised placebo-controlled phase II neo-adjuvant study in muscle invasive bladder cancer. He served as chief investigator of various early phase trials, and translational studies. Professor Hussain has authored over 105 peer-reviewed publications including 4 book chapters in textbooks of oncology. His Google scholar H-index is 37 with over 8300 citations. He has published in high impact journals including New England Journal of medicine, Lancet, Lancet Oncology, JAMA, JAMA Oncology, Journal of Clinical oncology, European Urology, Annals of Oncology, Nature communications, Clinical Cancer Research, British journal of Cancer. He has been an invited speaker to number of national and international meetings. Professor Hussain has secured funding of over 10 million pounds from funding bodies.